The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Vygon sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Vygon SA (Vygon) is a medical specialty company that designs, manufactures, and markets single use medical and surgical products. The company offers products in various specialties and therapeutic areas such as such as pediatrics, neonatology, support for post-operative pain relief, anesthesia, emergency and intensive care units, vascular access, surgery, and home care, among others. The company manufactures its products at plants in Europe, Mauritius, Colombia, and the US and offers its products to healthcare professionals in hospital and independent practitioners. The company markets products directly and through a network of distributors across the Americas, Asia, Europe, the Middle East, and Africa. Vygon is headquartered in Ecouen, France. Key subsidiaries of Vygon include Vygon Bulgaria, Vygon, Vygon, Medwin and Vygon Italia.
The key metrics of Vygon related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Vygon is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Vygon.
For a detailed understanding of the performance of Vygon, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.